Basic Information
| LncRNA/CircRNA Name | HMLINCRNA717 |
| Synonyms | HMlincRNA717, GACAT2, MTCL1-AS1, MTCL1AS1 |
| Region | GRCh38_18:8695856-8707621 |
| Ensemble | ENSG00000265962 |
| Refseq | NR_120598 |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | Drug | |||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | pancreatic cancer |
| ICD-0-3 | C25 |
| Methods | qPCR etc. |
| Sample | prostate cancer tissues |
| Expression Pattern | down-regulated |
| Function Description | The expression of HMlincRNA717 was significantly decreased in pancreatic cancer tissues compared with paired adjacent normal tissues. It was also proved that HMlincRNA717 expression was to be associated with clinical stage, tumor size, lymph node metastasis, and distant metastasis in pancreatic cancer patients. |
| Pubmed ID | 27338046 |
| Year | 2016 |
| Title | Association of LncRNA HMlincRNA717 with prognosis in pancreatic cancer. |
External Links
| Links for HMLINCRNA717 | GenBank HGNC NONCODE |
| Links for pancreatic cancer | OMIM COSMIC |